Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Hims & Hers shares tanked after regulators signaled new limits on the production of versions of weight-loss drugs.

According to the Journal, the GLP-1 "pricing fight" began in late 2023, when Lilly priced Zepbound at $1,060 per month, or 20% lower than Novo Nordisk's Wegovy. Analysts told the newspaper that prices ...

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...

Novo Nordisk's CEO faced lawmakers in a grueling 2.5-hour hearing to discuss the cost of blockbuster drugs Ozempic and Wegovy ...

Here are five key takeaways: During the hearing, Novo Nordisk CEO Lars Fruergaard Jørgensen attributed the high prices of drugs such as Ozempic and Wegovy to PBMs, arguing that "a high list price is ...

Kourtney Kardashian Barker's supplement brand, Lemme, is the latest to jump on the Ozempic craze. The brand, which launched in September 2022, sells a line of gummy vitamins such as Lemme Chill ...

According to a recent article in the American Journal of Managed Care, the list price for GLP-1 drugs can range from $936 to $1,349 before insurance and other discounts. Costs are rising so fast ...

The plaintiffs' attorneys claim that GLP-1 drugs — specifically Ozempic ... the litigation against the pharmaceutical giants, 85% list gastroparesis as an alleged injury. Gastroparesis occurs ...

Unfortunately, there is a catch, Hims' ability to sell GLP-1 depends on the drug's current status as being listed on the FDA shortage list. This enables Hims and other players to sell versions of ...